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Lipopolysaccharide (LPS) is a major glycolipid present in the outer membrane (OM) of Gram-negative
bacteria. The peculiar permeability barrier of the OM is due to the presence of LPS at the outer leaflet of this
membrane that prevents many toxic compounds from entering the cell. In Escherichia coli LPS synthesized
inside the cell is first translocated over the inner membrane (IM) by the essential MsbA flippase; then, seven
essential Lpt proteins located in the IM (LptBCDF), in the periplasm (LptA), and in the OM (LptDE) are
responsible for LPS transport across the periplasmic space and its assembly at the cell surface. The Lpt
proteins constitute a transenvelope complex spanning IM and OM that appears to operate as a single device.
We show here that in vivo LptA and LptC physically interact, forming a stable complex and, based on the
analysis of loss-of-function mutations in LptC, we suggest that the C-terminal region of LptC is implicated in
LptA binding. Moreover, we show that defects in Lpt components of either IM or OM result in LptA
degradation; thus, LptA abundance in the cell appears to be a marker of properly bridged IM and OM.
Collectively, our data support the recently proposed transenvelope model for LPS transport.
Lipopolysaccharide (LPS) is a complex glycolipid uniquely
present in the outer layer of Gram-negative bacteria outer
membrane (OM) (20, 21). LPS, also known as endotoxin, is
one of the major virulence factors of Gram-negative bacteria
and is responsible for the activation of the mammalian innate
immune response (17). It consists of three distinct structural
elements: lipid A (the hydrophobic moiety embedded in the
OM), a core oligosaccharide, and the O antigen constituted of
polysaccharide repeating units (21). LPS is essential in most
Gram-negative bacteria, with the notable exception of Neisse-
ria meningitidis (32). The lipid A-core moiety is synthesized in
the cytoplasm and is flipped from the inner to the outer leaflet
of the inner membrane (IM) by the essential ABC transporter
MsbA (6, 19, 43). In bacterial strains producing the O antigen,
ligation to the core oligosaccharide occurs at the periplasmic
face of the IM, after MsbA-mediated translocation (21). Ma-
ture LPS, containing or not the O antigen, is then transported
to the outer leaflet of the OM by a protein machine composed
of seven recently discovered Lpt proteins (reviewed by Spe-
randeo et al. [28]) suggested to build up a complex (the Lpt
complex) that spans the IM and OM. Indeed, these proteins
are located at the IM (LptBCFG), in the periplasm (LptA),
and at the OM (LptDE) (3, 23, 27, 29, 30, 33, 41). Genetic
evidence suggests that the Lpt complex operates as a single
device, since the depletion of any component leads to similar
phenotypes, namely, failure to transport newly synthesized
LPS to the cell surface and its accumulation at the outer leaflet
of the IM (16, 23, 29). The LPS accumulating at the outer
leaflet of the IM is decorated with colanic acid residues, and
therefore this modification is diagnostic of defects in transport
occurring downstream of the MsbA-mediated flipping of LPS
to the periplasmic face of the IM (29).
Physical interaction between the different proteins of the
machinery has been demonstrated for LptDE, which form a
complex at the OM (41), and for the IM LptBCFG complex
(18). LptD and LptE are responsible for the LPS assembly at
the cell surface; LptE stabilizes LptD by interacting with its
C-terminal domain, whereas LptE binds LPS, possibly serving
as a substrate recognition site at the OM (5). LptC is an IM
bitopic protein whose large soluble domain has a periplasmic
localization (38). The crystal structure of LptC periplasmic
domain has been recently solved and, like LptA, LptC has been
shown to bind LPS in vitro (38). LptC physically interacts with
the IM LptBFG proteins, and the LptBCFG complex is the IM
ABC transporter that energizes the LPS transport (18). How-
ever, LptC seems not to be required for the ATPase activity of
the transporter (18).
LptA expressed from an inducible promoter has a periplas-
mic localization and has been shown to bind both LPS and lipid
A in vitro (27, 39). These data raise the possibility that LptA
may act as a periplasmic chaperone for LPS transport across
the periplasm. However, in N. meningitidis the LptA homo-
logue was shown to be associated to the membrane fraction
(2). Moreover, in the Escherichia coli LptA crystal structure
obtained in the presence of LPS, the LptA monomers are
packed as a linear filament (34), leading to the hypothesis that
oligomers of LptA may be required to bridge the IM and the
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OM, thus facilitating LPS export. The observation that LPS is
still transported to the OM in spheroplasts devoid of periplas-
mic content (35) is consistent with this idea. In line with these
data it has been recently reported that all seven Lpt proteins
physically interact and form a transenvelope complex spanning
IM and OM (4).
In the present study we show that in vivo LptA and LptC
physically interact and form a stable complex, suggesting that
LptC may represent a docking site for LptA to the IM. Based
on analyses of loss-of-function mutations in LptC, we predict
that the C-terminal region of LptC is implicated in LptA bind-
ing and that LptC may form dimers. Finally, after analyzing the
relative stability of the Lpt proteins when LptC, LptD, or LptE
are either depleted or not functional, we suggest that LptA
connects IM and OM via LptC and the LptDE complex and
that LptA abundance in the cell may be used as a marker of
properly bridged IM and OM.
MATERIALS AND METHODS
Bacterial strains and media. The bacterial strains and plasmids examined here
are listed in Table 1. The oligonucleotide primers are listed in Table 2.
Bacteria were grown in LD medium (24). When required, 0.2% (wt/vol)
L-arabinose (as an inducer of the araBp promoter), 0.1 or 0.5 mM IPTG (iso-
propyl--D-thiogalactopyranoside), 100 g of ampicillin/ml, 25 g of chloram-
phenicol/ml, and 25 g of kanamycin/ml were added. Solid media were prepared
as described above with 1% agar.
Plasmid construction. Plasmid pGS108 expresses LptC with a C-terminal His6
tag (LptC-H) from the IPTG-inducible Ptac promoter (Table 1). Plasmids
pGS108G56V, pGS103G153R, and pGS108G153R expressing LptCG56V-H,
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant characteristicsa Source or reference
Strains
AM604 MC4100 ara 41
AM661 AM604 lptD::kan/araBp-lptD 29
AM689 AM604 lptE::kan (att-lom)::bla araBp-lptE 41
DH5 (argF-lac169) 80dlacZ58(M15) glnV44(AS)  rfbD1 gyrA96 recA1 endA1 spoT1 thi-1 hsdR17 11
FL905 AM604 (kan araC araBp-lptC)1 29
FL907 AM604 (kan araC araBp-lptA)1 29
M15/pREP4 F lac thi mtl/pREP4 Qiagen
Plasmids
pRSET T7 promoter; Apr Invitrogen
pET30b T7 promoter; Kmr Novagen
pET30-lptC-lk25-H pET30b derivative, expresses a LptC-lk25-His6 version where lk is a 25-amino-acid linker
region separating LptC residue 191 from the His6 affinity tag
This study
pQE30 T5 promoter; Apr Qiagen
pQEsH-lptC pQE30 derivative, expresses His6-LptC24-191 This study
pGS100 pGZ119EH derivative, contains TIR sequence downstream of Ptac; Cmr 30
pGS103 pGS100 Ptac-lptC 30
pGS103177-191 pGS103 Ptac-lptC177-191 This study
pGS103G56V pGS103 Ptac-lptC(G56V) This study
pGS103Y112S-G153R pGS103 Ptac-lptC(Y112S-G153R) This study
pGS103G153R pGS103 Ptac-lptC(G153R) This study
pGS108 pGS100 Ptac-lptC-H 30
pGS108177-191 pGS108 Ptac-lptC177-191-H This study
pGS108G153R pGS108 Ptac-lptC(G153R)-H This study
pGS108G56V pGS108 Ptac-lptC(G56V)-H This study
pGS116 pGS103177-191 derivative expressing both the truncated LptC177-191 and LptC-lk25 from
pET30- lptC-lk25-H plasmid
This study
a Cmr, chloramphenicol resistance; Apr, ampicillin resistance; Kmr, kanamycin resistance.
TABLE 2. Oligonucleotides
Name Sequence (5	–3	)a Use and/or description
AP24 cgactagtctagaTTAAGGCTGAGTTTGTTTG Random mutagenesis with AP54; XbaI
AP54 cgagaggaattcaccATGAGTAAAGCCAGACGTTGGG pGS108177-191 construction, with AP172 and random
mutagenesis with AP24; EcoRI
AP149 atatacatATGAGTAAAGCCAGACGTTG pET30-lptC-H construction, with AP150; NdeI
AP150 cgcgcaggtaccAGGCTGAGTTTGTTTGTTTTG pET30-lptC-H construction, with AP149; KpnI
AP164 GTCTATAACCCAGAAGTGGCACTAAGCTATCG pGS108G56V construction, with AP165
AP165 CGATAGCTTAGTGCCACTTCTGGGTTATAGAC pGS108G56V construction, with AP164
AP166 cgagatggatccATGGCCGAAAAAGACGATAC pQEsH-lptC construction, with AP167; BamHI
AP167 cgagatctgcagTTAAGGCTGAGTTTGTTTG pQEsH-lptC construction, with AP166; PstI
AP168 CTCGTCACGTTATACAGAACAACATTTAACTC pGS108G153R and pGS103G153R construction, with AP169
AP169 GAGTTAAATGTTGTTCTGTATAACGTGACGAG pGS108G153R and pGS103G153R construction, with AP168
AP172 gtgatcacatctagatcagtggtggtggtggtggtgTTCAATCAGCTCGGCGTTC pGS108177-191 construction, with AP54; insertion of C-
terminal His6 tag into LptC177-191; XbaI
a Uppercase letters, E. coli genomic sequence; underlined lowercase letters, restriction sites; boldface letters, codons mutated by site-directed mutagenesis.
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LptCG153R, and LptCG153R-H, respectively, were constructed by using a
QuikChange site-directed mutagenesis kit (Stratagene). Codon 56 was changed
from GGG to GTG by using the primer pair AP164-AP165, and codon 153 was
changed from GGA to AGA by using the primer pair AP168-AP169 (Table 2).
Plasmid pGS108177-191 expressing LptC177-191-H, truncated at residue 177,
was constructed by PCR amplifying the lptC open reading frames from genomic
MG1655 DNA with the primer pair AP54-AP172 (Table 2). The PCR product
was EcoRI-XbaI digested and cloned into pGS108 cut with the same enzymes.
The EcoRI-XbaI insert in pGS108177-191, as well as the mutations in
pGS108G56V, pGS108G153R, and pGS103G153R, was verified by sequencing.
Plasmid pQEsH-lptC expresses a soluble cytoplasmic version of LptC deprived
of the transmembrane helix and with an N-terminal His6 affinity tag (sH-LptC)
(Table 1). A 507-bp DNA fragment, encoding residues 24 to 191 of LptC, was
amplified from MG1655 DNA with the primers AP166 and AP167 (Table 2) and
cloned into the BamHI and PstI sites of pQE30 (Qiagen). The His6 affinity tag
is separated from the first residue of LptC24-191 by two amino acids (G-S). The
BamHI-PstI insert was verified by sequencing.
Plasmid pET30-lptC-lk25-H expresses a C-terminally His6-tagged version of
LptC (LptC-lk25-H) with a 25-amino-acid linker region (GTDDDDKAMAISD
PNSSSVDKLAAALE) containing the enterokinase recognition site (DDDDK)
(Table 1). The lptC open reading frame was amplified from MG1655 DNA with
the primers AP149 and AP150 (Table 2). The PCR product was NdeI-KpnI
digested and cloned into the NdeI-KpnI sites of pET30b (Novagen). The NdeI-
KpnI insert was verified by sequencing.
Plasmid pGS116 is a pGS103177-191 derivative expressing LptC-lk25, together
with LptC177-191 from the IPTG-inducible Ptac promoter (Table 1). The XbaI-
HindIII fragment of pET30-lptC-lk25-H, containing the ribosome binding site
(RBS) region, the lptC gene without its stop codon and part of the plasmid
multiple cloning site was inserted into the XbaI-HindIII sites of pGS103177-191.
The resulting plasmid expresses LptC (LptC-lk25) in frame with a 27-amino-acid
coding sequence (GTDDDDKAMAISDPNSSSVDKLGCFGG). In this con-
struct the His6 affinity tag is lost.
Random mutagenesis, screening, and genetic characterization of LptC mu-
tants. Random mutagenesis was performed by error-prone PCR using an un-
balanced deoxynucleoside triphosphates concentration in the amplification re-
actions, as described previously (9). pGS103 expressing lptC from the Ptac
promoter was used as a template (10 ng) in 50 l with 50 pmol each of primers
AP54 and AP24 (Table 2). The PCR conditions were as follows: 95°C denatur-
ation for 2 min; 30 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 1 min;
followed by a 5-min extension at 72°C. The products were gel purified, digested
with XbaI and EcoRI, ligated into pGS100, and electroporated into FL905 cells.
The transformants were plated onto LD agar with 0.2% arabinose and 25 g of
chloramphenicol/ml at 37°C. Single colonies were then inoculated into microtiter
wells containing 100 l of LD, serially diluted 10-fold, replica plated on LD-
chloramphenicol agar plates supplemented with (permissive condition) or with-
out (nonpermissive condition) 0.2% arabinose, and incubated overnight at 37°C.
Plasmids unable to support FL905 growth in the absence of arabinose were
identified and sequenced.
To test the effect of LptC mutant overexpression, serial dilutions of cultures
grown overnight in LD-chloramphenicol were replica plated on LD-chloram-
phenicol agar plates supplemented or not with 0.5 mM IPTG.
In vivo cross-linking. The cross-linking experiments were based on previously
described methods (36) with some modifications. The cells were grown in 250 ml
of LD medium supplemented with either chloramphenicol or ampicillin to an
optical density at 600 nm (OD600) of 0.2, induced with 0.1 mM IPTG, and grown
to an OD600 of 
0.7. The cells were then harvested by centrifugation at 5,000 
g for 10 min. For treatment with DSP (di-thiobis[succinimidyl propionate];
Pierce), the cell pellet was washed with 25 ml of 20 mM potassium phosphate
(pH 7.2) and 150 mM NaCl, resuspended in 25 ml of the same buffer, and then
incubated for 15 min at 37°C. DSP dissolved in dimethyl sulfoxide was added to
the cell suspension at a final concentration of 80 g/ml, and the cells were
incubated for 30 min at 37°C. The cross-linking reaction was quenched by the
addition 1 M Tris-HCl (pH 7.4) to a final concentration of 20 mM, and the cells
were harvested by centrifugation at 5,000  g for 10 min.
For whole-cell extract analysis, the cells were grown in 50 ml of LD-chloram-
phenicol to an OD600 of 0.2, induced with 0.1 mM IPTG, and grown to an OD600
of 
0.7. DSP treatment was performed as described above using two-thirds of
each culture, whereas the reminder one-third was not treated. After the addition
of 20 mM Tris-HCl (pH 7.4), the cells were centrifuged and washed twice in 20
mM potassium phosphate (pH 7.2) and 150 mM NaCl. The cell pellet was
resuspended in 100 l of sodium dodecyl sulfate (SDS) sample buffer containing
or not containing 5% -mercaptoethanol and boiled for 5 min.
Affinity purification. Protein purification was performed as described previously
(26). The cell pellets were resuspended in 4 ml of 50 mM potassium phosphate buffer
(pH 8.0), 150 mM NaCl, 5 mM MgCl2, and 1% ZW3-14 (n-tetradecyl-N,N-dimethyl-
3-ammonio-1-propanesulfonate) containing lysozyme (50 g/ml), DNase I (50 g/
ml), and RNase I (50 g/ml) and then lysed by shaking for 20 min at room temper-
ature. To remove cell debris after lysis, the mixture was then centrifuged at 10,000
g for 10 min. To the cleared lysate (whole-cell extract) 20 mM imidazole (pH 8.0)
was added, and the final mixture was loaded onto a 0.4-ml Ni-NTA column. The
column was first washed with 8 ml of 50 mM potassium phosphate buffer (pH 8.0),
300 mM NaCl, 20 mM imidazole, 0.1% Triton X-100, and 0.1% SDS and then eluted
with 4 ml of 50 mM potassium phosphate buffer (pH 8.0), 300 mM NaCl, and 200
mM imidazole. The eluate was concentrated in an ultrafiltration device (Amicon
Ultra [Millipore]; molecular weight cutoff, 10,000) by centrifugation at 5,000  g.
The concentrated sample was used for SDS-PAGE and Western blot analysis as
described above.
Purification of sH-LptC. M15/pREP4 carrying the plasmid pQEsH-lptC was
grown at 30°C in LD containing kanamycin (25 g/ml) and ampicillin (100
g/ml) for 18 h. This culture was diluted 1:100 in fresh medium and grown until
mid-logarithmic phase (OD600, 
0.6). The expression of sH-LptC was induced
overnight at 20°C by adding IPTG to a final concentration of 0.5 mM. Cells were
then harvested by centrifugation (5,000  g, 10 min). The cell pellet was resus-
pended in buffer A (50 mM NaH2PO4 [pH 8.0] containing 300 mM NaCl, 10 mM
imidazole, and 10% glycerol), followed by incubation for 30 min at 4°C with
shaking in the presence of lysozyme (0.2 mg/ml), DNase (100 g/ml), 10 mM
MgCl2, and 1 mM phenylmethylsulfonyl fluoride. After 10 cycles of sonication
(10-s pulses), the unbroken cells were removed by centrifugation (39,000  g, 30
min). The soluble sH-LptC protein was purified from the supernatant by using
Ni-NTA agarose (Qiagen). The column was washed with 10 column volumes of
4% buffer B (50 mM NaH2PO4 [pH 8.0] containing 300 mM NaCl, 500 mM
imidazole, and 10% glycerol) in buffer A. The protein was eluted by using a
stepwise gradient obtained by mixing buffer B with buffer A in 5 steps (10, 20, 50,
70, and 100% buffer B). At each step, 1 column volume was flowed through the
column. Elution fractions were monitored by 12.5% polyacrylamide SDS-PAGE.
The pooled fractions containing purified protein were dialyzed against 100 vol-
umes of buffer C (50 mM NaH2PO4 [pH 8.0], 100 mM NaCl) for gel filtration
analysis, and 100 volumes of 10 mM ammonium acetate pH 7.5 for mass spec-
trometry. Protein concentrations were determined by using a Coomassie (Brad-
ford) assay kit (Pierce) with bovine serum albumin as the standard.
Mass spectrometry. Electrospray ionization-mass spectrometry (ESI-MS) ex-
periments were performed on a hybrid quadrupole-time-of-flight mass spectrom-
eter (QSTAR Elite; Applied Biosystems, Foster City, CA) equipped with a
nano-ESI sample source. Metal-coated borosilicate capillaries (Proxeon,
Odense, Denmark), with medium-length emitter tips (1-m internal diameter),
were used to infuse the samples. The instrument was calibrated using the renin
inhibitor (1,757.9 Da) (Applied Biosystems) and its fragment (109.07 Da) as
standards. Spectra were acquired in the 500 to 5,000 m/z range, with accumula-
tion times of 1 s, an ion-spray voltage of 1,300 V, a declustering potential of 40
V, and an instrument interface at room temperature. Spectra were averaged over
a period of at least 3 min.
Analytical gel filtration chromatography. Size-exclusion chromatography was
performed on an A¨KTA purifier liquid-chromatography system (GE Healthcare,
Amersham Place, Little Chalfont, United Kingdom), using a prepacked, Super-
dex 75HR column (30 by 1 cm; GE Healthcare, Amersham Place, Little Chal-
font, United Kingdom). Chromatography was carried out at room temperature
in 50 mM NaH2PO4 (pH 8.0)–100 mM NaCl at a flow rate of 0.5 ml/min and
monitored by the eluate absorbance at 280 nm. The calibration curve was con-
structed by using the following standards (0.5 mg/ml): transferrin (81,000 Da),
chicken ovalbumin (43,000 Da), chymotrypsin (21,500 Da), bovine cytochrome c
(12,200 Da), and aprotinin (6,500 Da) (Sigma Aldrich, St. Louis, MO). LptC was
injected at a concentration of 1 mg/ml.
Determination of LptA, LptC, and LptE levels. LptA, LptC, and LptE levels
were assessed in FL905 and its derivatives expressing mutant LptC or in AM661
or AM689 strains by Western blot analysis with polyclonal antibody raised in
mouse or rabbit against peptides (LptA) or whole proteins (LptE, LptC, and
AcrB). Bacterial cultures grown at 37°C in LD supplemented with 0.2% arabi-
nose and 25 g of chloramphenicol/ml when required were harvested by cen-
trifugation after they had reached an OD600 of 0.2, washed in LD, and diluted to
OD600s of 0.01 (AM689), 0.004 (AM661), 0.0004 (AM604, FL905/pGS103177-191,
FL905/pGS103, FL905, FL905/pGS103G56V, and FL905/pGS108G153R) in
fresh media with or without 0.2% arabinose and with 25 g of chloramphenicol/
ml. Growth was monitored by measuring the OD600. Samples for protein analysis
were centrifuged (16,000  g, 5 min), and pellets were resuspended in a volume
(in ml) of SDS sample buffer equal to one-eighth of the total OD of the sample.
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The samples were boiled for 5 min, and equal volumes (25 l) were analyzed by
SDS–12.5% PAGE. Proteins were transferred onto nitrocellulose membranes
(GE Healthcare), and Western blot analysis was performed as previously de-
scribed (27). Polyclonal sera raised against LptA (GenScript Corp.) were used as
primary antibody at a dilution of 1:2,000, whereas polyclonal sera against LptC,
LptE (kindly provided by D. Kahne), and AcrB (kindly provided by K. M. Pos)
were used at a dilution of 1:5,000. As secondary antibodies, sheep anti-mouse
immunoglobulin G–horseradish peroxidase (HRP) conjugate (GE Healthcare)
and donkey anti-rabbit immunoglobulin G–HRP conjugate (GE Healthcare)
were used at dilutions of 1:5,000.
Analyses of LptC-H mutant stability. The expression of LptC was induced with
0.1 mM IPTG at an OD600 of 0.3 to 0.4 in cultures grown in LD-chloramphen-
icol, and 1-ml samples were taken immediately before and 15, 30, and 60 min
after induction. Samples preparation and Western blotting were performed as
described above, and wild-type and mutant versions of LptC-H were visualized
by using HisProbe-HRP (Pierce) according to the manufacturer’s instructions.
Total LPS extraction and analysis. LPS extraction from AM604 and FL905
transformed or not with plasmids carrying wild-type or mutant LptC was per-
formed as previously described. Samples of a total OD600 of 2 were taken, and
LPS was extracted from cell pellets by a mini phenol-water extraction technique
(22). Briefly, the cells were resuspended in water and pelleted (5 min, 10,000 
g) to remove the exopolysaccharides and then resuspended in 0.3 ml of potassium
phosphate buffer (pH 7.0) and thoroughly vortexed; 0.3 ml of phenol equilibrated
with 0.1 M Tris-HCl (pH 5.5) was added, and the suspension was vortexed. The
tubes were placed in a 65°C heating block for 15 min with thorough vortexing
every 5 min and then cooled on ice. After centrifugation (10,000  g, 5 min), the
water phase was removed, dialyzed (molecular mass cutoff, 2,000 to 4,000 Da)
against phosphate buffer (pH 7.0), and lyophilized. The lyophilized material was
then dissolved in 30 l of water. LPS was separated by N-[2-hydroxy-1,1-bis(hy-
droxymethyl)ethyl]glycine–SDS-PAGE (31) and visualized by silver staining ac-
cording to the Hitchcock and Brown method as described previously (27).
RESULTS
LptC stably associates with LptA. Previous work by our and
other laboratories (27, 39) suggested that LptA expressed from
an inducible promoter has a periplasmic localization. However,
evidence of direct physical interaction between the seven Lpt
proteins has been recently reported and LptA has been shown
to associate with both IM and OM (4). Since the bitopic IM
LptC protein possesses a large C-terminal periplasmic domain
(E26-P191) (38), we hypothesized that LptA binding to the IM
could be mediated by LptC. To address this issue, we probed
the interaction between LptA and LptC by affinity purification
followed by immunoblotting. A C-terminal His tagged version
of LptC (LptC-H) overexpressed from plasmid pGS108 in the
wild-type strain AM604 was used as bait in copurification ex-
periments. AM604 harboring the pRSET vector, which allows
the basal expression of the His tag alone, was used as a nega-
tive control. To detect possible weak or transient interactions,
in vivo cross-linking using di-thiobis(succinimidyl propionate)
(DSP) (42) was also performed. As shown in Fig. 1, LptA
copurified with LptC-H even when DSP was not added to the
cells overexpressing LptC-H, suggesting a stable LptA-LptC
interaction. When samples treated with DSP were not reverted
by a reducing agent, high-molecular-weight bands appeared
(Fig. 1, upper and lower panel, bands C1 and C2). C1 may
correspond to an LptA-LptC complex, whereas the C2 band
that appears only in the lower panel might correspond to an
LptC-LptC complex, as inferred by the molecular weight.
These data suggest that LptA and LptC interact and form a
stable complex.
Isolation of inactive lptC mutant alleles. To better charac-
terize LptA-LptC interaction and to define the molecular role
of LptC in LPS transport, we searched for point mutations that
inactivate LptC function. Random mutations were introduced
by error-prone PCR into lptC carried by pGS103 (Table 1), and
the mutagenized plasmids were tested for complementation of
LptC-depleted cells, as described in Materials and Methods.
Briefly, LptC depletion strain FL905 was transformed with
the mutagenized plasmids in the presence of arabinose, and
plasmids unable to support FL905 growth in the absence of
arabinose were isolated. Of 1,664 transformants analyzed, we
obtained 21 clones unable to fully complement FL905 in the
nonpermissive conditions. Most noncomplementing clones
harbored multiple mutations, as assessed by sequencing the
mutant alleles. Nevertheless, three plasmids harbored only one
or two mutations in LptC (Fig. 2A), namely, G56V, K177Stop
(which generates a truncated protein lacking the C-terminal 15
amino acids [177-191]), and Y112S-G153R (a double substitu-
tion mutant in the C-terminal region). FL905/pGS103177-191
and FL905/pGS103Y112S-G153R growth was completely in-
hibited on agar medium in the absence of arabinose, whereas
FL905/pGS103G56V growth was severely impaired in the ab-
sence of arabinose and formed “dust-like colonies” in this
condition (Fig. 2B).
FIG. 1. LptA interacts with LptC in vitro. Affinity chromatography
experiments were performed in the presence or absence of DSP in
AM604/pGS108 overexpressing LptC-H (wt/LptC-H) and AM604/
pRSET (wt/none) expressing the His tag element only, as a negative
control. LptA and LptC were detected in Ni-NTA column-enriched
fractions by Western blot analysis with anti-LptA antibody and His-
Probe-HRP, respectively. LptA detected in crude cell extract (CE) of
AM604 (wt) and of FL907 mutant overexpressing LptA (araBp-lptA)
was used as a marker. Samples were treated with dithiothreitol (DTT)
and/or -mercaptoethanol (-ME) to revert the cross-linking. Equal
amounts of protein (2 g) were loaded into each lane. C1 and C2,
high-molecular-weight complexes. The SlyD protein of 24 kDa cross-
reacting with anti-LptA antibodies is labeled ().
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The G153R substitution was also found in other multiple mu-
tants isolated in our screening associated with different amino
acid substitutions, suggesting that G153R could be the residue
responsible of the observed phenotype. This was confirmed by the
fact that both pGS103G153R and pGS108G153R, which ex-
presses a His6-tagged LptCG153R mutant protein generated by
site-directed mutagenesis (LptCG153R-H) (Table 1), were un-
able to complement FL905 (Fig. 2B). In all of the experiments
described below, FL905/pGS108G153R was used. The mutations
described above fall in conserved regions of the protein (see, for
example, the sequence alignments of LptC orthologues from pro-
teobacteria in reference 38).
Stability of the LptC mutant proteins. To assay the stability
of LptC mutant proteins, we examined the level of ectopically
expressed LptC-H (which can be distinguished from the en-
dogenous wild-type protein) and its mutant derivatives in the
wild-type strain AM604 upon induction with IPTG, assuming
that the level of de novo-synthesized proteins correlates with
their stability. It should be noted that in these conditions the
chromosomal wild-type copy of lptC is expressed from its nat-
ural promoter. Detection of the proteins using HisProbe-HRP
revealed that the level of LptCG56V-H was comparable to that
of LptC-H and only the basal level (before IPTG induction) of
LptCG153R-H was affected, suggesting that this protein is only
slightly unstable (Fig. 3A). On the contrary, the level of the
truncated LptC177-191-H protein was severely reduced under
these conditions, indicating that the truncated protein is intrin-
sically unstable.
We then tested the effect of LptC mutants overexpression on
E. coli growth by plating wild-type strain AM604 harboring
pGS108, pGS108G56V, pGS108177-191, and pGS108G153R
on agar medium in the absence or in the presence of IPTG.
Overexpression of LptCG56V did not impair growth; on the
contrary, we found that overexpression of 177-191 and G153R
LptC-H mutants abolished AM604 growth (Fig. 3B). Since
LptC is part of a multiprotein complex these data suggest that
either the mutants may titrate a wild-type interacting Lpt fac-
tor(s) or that their toxicity may be due to the overexpression of
a misfolded protein.
The C-terminal region of LptC is required for LptA binding.
To test whether the G56V, 177-191, and G153R mutations
could affect LptC interaction with LptA, we compared the
wild-type and the mutant proteins for their ability to copurify
FIG. 2. Mutations affecting LptC function. (A) Mutations in the
lptC gene in the pGS103-derived plasmids. Nucleotide coordinate
numbers are based on the designation of the start codon of lptC as 1.
The amino acid numbers are based on the predicted sequence of LptC
that is 191 amino acids in length. (B) Plating efficiency of FL905
(araBp-lptC) transformed with plasmid pGS103 carrying the wild-type
protein (LptC and LptC-H, respectively), or plasmids carrying the
LptC mutated proteins LptCG56V, LptC177-191, LptCG153R,
LptCG153R-H, or plasmid pGS100 (none), in agar plate containing
chloramphenicol supplemented () or not () with arabinose. Serial
dilutions are given on the left side of the panel.
FIG. 3. LptC mutant stability in vivo and effects of their overexpression. (A) LptC mutant stability. AM604 cells harboring pGS108 (LptC-H),
pGS108G56V (LptCG56V-H), pGS108G153R (LptCG153R-H), and pGS108177-191 (LptC177-191-H) were grown to the early logarithmic phase.
Expression of LptC-H or its mutant forms were induced by the addition of 0.1 mM IPTG. Samples for protein analysis were obtained 0, 15, 30,
and 60 min postinduction and analyzed using HisProbe-HRP. Equal amount of cells (0.12 OD600 units) was loaded into each lane. (B) Overex-
pression of LptC177-191 and LptCG153R leads to cell lethality. Serial dilutions (indicated on the left) of overnight cultures of AM604 carrying the
plasmids pGS108, pGS108G56V, pGS108177-191, and pGS108G153R were replica plated onto agar plate supplemented () or not () with 0.5
mM IPTG and incubated overnight.
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LptA. Whole-cell extracts of the wild-type strain AM604 over-
expressing LptC-H or the mutant His-tagged derivatives
(G56V, 177-191, and G153R; Table 1) were subjected to affin-
ity purification and LptA and LptC-H detected by Western
blotting with anti-LptA antibodies and HisProbe-HRP, respec-
tively. As shown in Fig. 4, LptCG56V-H retained the ability to
copurify LptA, whereas the mutations in the LptC C-terminal
region (G153R and 177-191) severely impaired LptA-LptC
complex formation.
Effects of different lptC alleles on Lpt complex and LPS
transport. To gain better insights into the molecular role of
LptC in the Lpt complex, we tested the effects of the three
lptC mutant alleles on the steady-state level of LptA and
LptE, the latter as a representative of the LptDE OM com-
plex, and on LPS transport. The LptC depletion strain
FL905 and its derivatives harboring pGS103, pGS103G56V,
pGS103177-191, and pGS108G153R were grown to the ex-
ponential phase and shifted into a medium lacking arabi-
nose (nonpermissive condition) to deplete the chromosom-
ally encoded LptC wild type, while allowing expression of
the mutant proteins. Samples were then taken from cul-
tures grown in the presence or absence of arabinose for 240
min (AM604, FL905, and FL905/pGS103) or 270 min
(FL905/pGS103G56V, FL905/pGS103177-191, and FL905/
pGS108G153R) after the shift to nonpermissive conditions
(Fig. 5A) and analyzed by Western blotting with anti-LptA,
anti-LptC, and anti-LptE antibodies. The level of the IM
protein AcrB was used as a sample loading control.
As shown in Fig. 5B (upper part), the level of physiologically
expressed LptC seemed very low since the protein was unde-
tectable in the wild-type strain with our antibody preparation.
However, LptC was detected when ectopically expressed from
a plasmid or from the araBp promoter (Fig. 5B). In FL905 cells
expressing LptCG56V and LptCG153R, the level of the mu-
tant proteins was comparable under permissive and nonper-
missive conditions, whereas LptC177-191 was undetectable in
the noncomplemented strain (see below).
In the LptC depletion strain FL905 grown in the presence
of arabinose, lptA is expressed from the upstream araBp pro-
moter, and the level of LptA is higher than in the wild-type
AM604 strain, where the protein is expressed from its natural
promoter (29). The level of LptA in LptC-depleted cells
expressing LptCG153R-H was similar to that observed in the
positive control (FL905 complemented by wild-type LptC),
whereas LptA appeared slightly more abundant in LptC-
depleted cells expressing LptCG56V. On the contrary, in non-
complemented LptC-depleted cells and in cells ectopically
expressing LptC177-191 LptA was undetectable. It thus ap-
pears that the absence of LptC protein caused by either de-
pletion (noncomplemented LptC-depleted cells) or mutation
(LptC-depleted cells expressing LptC177-191) induces LptA
destabilization. The abundance of LptE did not substantially
change upon depletion of LptC with or without overexpression
of any mutant LptC, indicating that the steady-state level of the
OM component LptE was not affected by LptC depletion or
mutations (Fig. 5B, upper part). The steady-state level of LptE
thus served in these experiments also as a sample loading
control.
Depletion of any Lpt protein leads to the production of LPS
decorated by colanic acid; this phenotype is diagnostic of de-
fects in LPS transport occurring downstream of the MsbA-
mediated flipping of lipid A-core to the periplasmic face of the
IM (29). We therefore analyzed the LPS profile in lptC mutant
strains. The total LPS was extracted from nondepleted and
LptC-depleted FL905 complemented with wild-type and mu-
tant lptC alleles, and the LPS profiles were analyzed as de-
scribed previously (29). As shown in Fig. 5B (lower part), LPS
decorated with colanic acid could be detected in LptC-de-
pleted FL905 complemented by each of the mutant alleles but
not by wild-type lptC, indicating that each of the above LptC
mutations impair LPS transport.
Evidence for LptC oligomerization in vivo. As noted above,
LptC177-191 mutant protein was not detectable upon deple-
tion of the chromosomally encoded LptC, whereas, when
LptC was coexpressed from the araBp promoter, the
LptC177-191 level was higher (notice that the wild-type and
truncated proteins can be distinguished by their different mo-
lecular weights; Fig. 5B, upper part). On the contrary, the
LptCG56V and LptCG153R mutant proteins remained abun-
dant upon depletion of wild-type LptC. LptC177-191 is an
intrinsically unstable protein (Fig. 3A) and appears to be sta-
bilized by overexpression of LptC, which is consistent with
the idea that LptC might interact with itself to form a dimer
(see also Fig. 1) or a multimer. An alternative explanation is
that upon depletion envelope stress response is triggered and
periplasmic proteases are induced that might degrade the un-
stable LptC truncated protein. To probe LptC oligomerization
in vivo, we performed in vivo cross-linking experiments using
the wild-type strain AM604 transformed with different LptC
constructs. In DSP-treated AM604 cells expressing wild-type
LptC a band of 
46 kDa was visible consistent with the for-
mation of an LptC-LptC complex (Fig. 6, upper panel). The
46-kDa band disappeared when the DSP cross-linker was re-
verted with a reducing agent. When samples were analyzed by
Western blotting with anti-LptA antibodies, a band of 
43
kDa was visible that possibly corresponded to an LptA-LptC
complex (Fig. 6, lower panel). In DSP-treated AM604 cells
expressing both LptC177-191 and an LptC version carrying an
additional 27 amino acids at the C-terminal end (LptC-lk25),
two high-molecular-mass bands with an apparent masses of
approximately 46 and 52 kDa appeared, possibly correspond-
ing to LptC-lk25–LptC177-191 and LptC-lk25–LptC-lk25 com-
FIG. 4. Effect of lptC mutations on LptC-LptA interaction. Whole-
cell extracts from AM604 cells transformed with plasmids pGS108
carrying the wild-type protein (LptC-H) or the LptC-mutated proteins
LptCG56V-H, LptCG153R-H, and LptC177-191-H were subjected to
affinity chromatography. Equal amounts (2.5 g) of Ni-NTA column-
enriched LptC-H and its mutant versions were separated by SDS–
12.5% PAGE and analyzed by Western blotting with anti-LptA anti-
body and HisProbe-HRP, respectively.
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FIG. 5. Effect of lptC mutations on Lpt proteins complex and LPS transport. (A) Growth curves of AM604 (wt; a), FL905 (araBp-lptC; b) strains
and FL905 carrying plasmids expressing LptC (c), LptCG56V (d), LptCG153R-H (e), and LptC177-191 (f). Cells growing exponentially in LD
containing arabinose were harvested, washed, and subcultured in arabinose-supplemented (}) or arabinose-free () medium. Growth was
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plexes. In DSP-treated cells expressing LptC177-191 the level
of the truncated protein was low compared to the LptC wild
type and LptC-lk25, a finding consistent with the notion that
the truncated protein is intrinsically unstable. However, an
high-molecular-mass band of 
44 kDa appeared, suggesting
that even the truncated protein is able to dimerize (Fig. 6,
upper panel). These data suggest that LptC can form dimers in
vivo. However, this experiment does not prove that dimeriza-
tion with wild-type LptC protects the truncated LptC177-191
protein version from degradation in the LptC depletion
strain FL905. Therefore, we examined the LptC levels in the
lptE depletion strain AM689 grown under permissive and non-
permissive conditions and expressing either the wild-type or
the truncated LptC177-191 proteins. As shown in Fig. 7,
LptC177-191 was undetectable when the lptE depletion strain
was grown in the absence of arabinose, an observation in line
with the idea that LptC177-191 is degraded by proteases in-
duced under stress conditions.
Purified LptC is a dimer in solution. In order to probe the
oligomeric state of LptC in vitro, the apparent molecular
weight of the pure protein was tested by size-exclusion chro-
matography and ESI-MS under nondenaturing conditions. To
do this, a preparation of the soluble version of LptC with an
N-terminal His6 tag and lacking the first 23 amino acids of the
transmembrane domain was analyzed (sH-LptC [see Materials
and Methods]) by size-exclusion chromatography. The protein
eluted as a single, slightly asymmetric peak on a Superdex75
column (Fig. 8A, inset). The LptC elution volume corre-
sponded to an estimated molecular mass of 
43,000 Da, rel-
ative to globular calibrants in the range 6,500 to 81,000 Da
(Fig. 8A), suggesting a dimeric assembly. This conclusion was
confirmed by nano-ESI-MS, which provides complementary
information by direct detection and weighing of protein non-
covalent complexes (13, 14). In Fig. 8B, C, and D, the spectra
of pure sH-LptC preparations in the presence of ammonium
acetate, which is known to favor detection of protein com-
plexes by mass spectrometry, are reported. At 5 M protein
and 50 mM ammonium acetate (Fig. 8B), the spectrum shows
signals of LptC monomers and dimers. Mass deconvolution
gives a value of 20,536.8 (0.25) Da for the monomer and
41,073.9 (1.02) Da for the dimer which are in close agree-
ment with the values calculated from the amino acid sequence
(20,535.85 Da for the monomer and 41,071.7 Da for the
dimer). Both species are characterized by conformational het-
erogeneity, as indicated by multimodal charge-state distribu-
tions (15), with maxima at 10, 15, and 23 for the mono-
mer and at 14 and 21 for the dimer. A 10-fold increase in
the ionic strength results in a simpler spectrum, with only one
monomeric and one dimeric species centered, respectively, on
the 10 and 14 ions (Fig. 8C). This result suggests that the
conformational heterogeneity observed at a lower ionic
strength might reflect partial protein unfolding induced by the
experimental conditions used. In Fig. 8D, the effect of protein
concentration on the spectrum at high ionic strength is shown.
monitored by measuring the OD600. Samples for protein and LPS analyses were taken from cells grown in the presence (ara) or absence (ara)
of arabinose at 240 (wt, FL905, and FL905/pGS103) or 270 min (FL905/pGS103G56V, FL905/pGS108G153R, and FL905/pGS103177-191) after
the shift into fresh medium. (B) Steady-state levels of LptA, LptC, and LptE and LPS profile. Protein samples were subjected to Western blot
analysis with anti-LptA, anti-LptC, anti-LptE, and anti-AcrB (as a loading control) antibodies. Anti-LptE antibodies cross-react with LptC-H His
tag (). Total LPS was extracted from mutant cells grown in the same conditions and at the same time points of protein analysis. LPS extracted
from cultures with a total OD600 of 2 were separated by 18% Tricine-SDS-PAGE and silver stained. Equal amounts of cells, based on the OD
measurement (0.2 OD600 units for protein analysis, 0.4 for LPS analysis), were loaded into each lane.
FIG. 6. LptC dimerization in vivo. Wild-type strain AM604 cells
transformed with different LptC constructs were treated with the cross-
linking DSP agent in vivo. Cell extracts were prepared and analyzed by
Western blotting with anti-LptC and anti-LptA antibodies. Samples
were treated with -mercaptoethanol (-ME) to revert the cross-link-
ing. Equal amount of cells, (1.6 OD600 units) was loaded into each
lane. An asterisk () labels a band that cross-reacts with the anti-LptC
antibody.
FIG. 7. Steady-state levels of LptA and LptC upon LptE depletion.
Protein samples from AM689 cells transformed with various plasmids
and grown in the presence () or absence () of arabinose 180 min
after a shift in the nonpermissive condition were analyzed by Western
blotting with anti-LptA, anti-LptC, and anti-LptE antibodies. Equal
amounts of cells (0.2 OD600 units) were loaded into each lane. AcrB
was used as a loading control.
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The relative intensity of the monomer decreases as the protein
concentration is increased from 5 to 20 M, a finding consis-
tent with a monomer-dimer equilibrium in the original liquid
sample. The calculated relative amount of the dimer is 
70%.
These data provide direct evidence of a predominant dimeric
state of LptC in solution. However, it should be underscored
that the apparent dissociation constant (in the micromolar
range, according to these results) could be affected by the
peculiar conditions imposed by electrospray. Overall, these
data suggest that the LptC dimerizes and that the soluble
portion of the protein is sufficient to promote dimerization.
Effect of LptD and LptE depletion on Lpt complex assembly.
The experiments described above showed that the steady-state
level of LptA is affected in the absence of wild-type LptC or by
the 177-191 mutation, which severely impairs LptC177-191 sta-
bility. It is possible that the absence of a proper IM docking
structure for LptA results in LptA degradation in vivo. There-
fore, the LptA level in the cell could be diagnostic of the
properly bridged IM and OM. We thus tested whether the
absence of the OM LptDE complex could also exert a similar
effect on LptA stability. The AM661 and AM689 strains, in
which the LptD and LptE expression is driven by the inducible
araBp promoter (29), were grown under permissive conditions
to exponential phase and then shifted to media lacking arabi-
nose to deplete LptD and LptE, respectively. Samples for
protein analyses were taken from cultures grown in the pres-
ence or in the absence of arabinose 210 min after the shift to
nonpermissive conditions (Fig. 9A) and then processed for
Western blot analysis with anti-LptA, anti-LptE, and anti-
AcrB antibodies. As shown in Fig. 9B, a decreased steady-state
level of LptA is observed upon LptE and LptD depletion.
Overall, our data suggest that when the Lpt machinery is not
functional for lack of either IM or OM components, LptA is
destabilized, probably because it is not properly assembled in
the Lpt complex.
DISCUSSION
LptA interaction with IM and OM Lpt components. The Lpt
proteins constitute a machinery for LPS transport to the cell
surface. Genetic and biochemical evidence indicates that the
components of the machinery work in a concerted way. In fact,
upon depletion of any of the seven Lpt proteins, the LPS
assembly pathway is blocked in nearly the same fashion (23,
29); moreover, it has been recently shown that the seven Lpt
proteins physically interact and constitute a transenvelope
complex connecting IM and OM (4). However, little is known
about how specific Lpt factors interact with each other. We
show here by copurification experiments that in vivo LptA
binding to IM occurs through binding to LptC, although we
cannot rule out the possibility that LptA may also interact with
FIG. 8. LptC dimerization in vitro. (A) Apparent molecular weight (MW) of LptC as determined by gel filtration. The relative elution volume
of sH-LptC in 50 mM sodium phosphate (pH 8.0)–100 mM NaCl was compared to that of globular standards. The chromatogram is shown in the
inset. Trf, transferrin; Ov, ovalbumin; Chy, chymotrypsin; Cytc, cytochrome c; Apr, aprotinin; Ve, elution volume; Vo, void volume; Abs, absorbance
at 280 nm. (B, C, and D) Quaternary structure of LptC by mass spectrometry. The nano-ESI-MS spectra of 5 M LptC in 50 mM ammonium
acetate (pH 7.5) (B), 5 M LptC in 500 mM ammonium acetate (pH 7.5) (C), and 20 M LptC in 500 mM ammonium acetate (pH 7.5) (D) are
shown. The main charge state of each peak envelope is labeled by the corresponding number of charges. Dimer-specific peaks are labeled by double
circles. Solid symbols correspond to compact dimers, and open symbols correspond to less compact dimers.
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other IM components such as LptFG, which possess periplas-
mic loops (23).
LptC depletion results in a significant decrease of LptA
level. Similarly, the LptA level in the cells decreases upon
LptD or LptE depletion, strongly suggesting that LptA also
interacts with the LptDE complex at the OM and that in a
non-properly assembled Lpt complex LptA may be degraded.
It is likely that LptC and the LptDE complex play a structural
role and prevent LptA degradation. Instability and/or degra-
dation of components of protein complexes when proven or
proposed interacting partners are either depleted or not func-
tional is not unusual and provides indirect evidence of physical
and functional interaction. The loss of any protein of the
PilMNOP IM complex required for biogenesis of type IV pili
in Pseudomonas aeruginosa results in instability of the other
interacting partners (1); similarly, EspL and EspM, which be-
long to the type II secretion pathway required for cholera toxin
secretion in Vibrio cholerae, have been shown to participate in
mutual stabilization by protecting each other from proteolysis
(25). Finally, Chng and coworkers demonstrated that LptD can
only be overexpressed with LptE and that purified LptE is
resistant to proteolytic degradation when in complex with
LptD, thus indicating a structural role of LptE in stabilizing
the folded state or facilitating the folding and assembly of
LptD (5).
Interaction of LptA with LptC and the LptDE complex
supports the model proposed by Kahne and coworkers (4),
which posits that LptA interacts with both the IM and the OM.
Consistent with this model are previous findings showing that
in the crystals obtained in the presence of LPS, the LptA
monomers are packed as a linear filament (34), suggesting that
LptA oligomerization is functional to bridging the IM and OM.
Since LptA consists of a conserved domain also found in the
N-terminal periplasmic domain of LptD, we suggest that the
latter protein may be the docking site for LptA at the OM (2,
30) and thus that LptA is anchored to the IM and OM through
LptC and LptD, respectively.
LptC structure-function relationship. The analysis of loss-
of-function mutations in lptC allowed us to further support the
structural role of LptC-LptA interaction in preventing LptA
degradation and to define functional regions in the LptC pro-
tein. The LptCG56V substitution falls in a stretch of relatively
conserved residues and, based on the recently reported crystal
structure, this residue is contained in one of the two disordered
regions of the protein (residues 24 to 58) where no electron
density was observed (38). The G56V amino acid substitution
does not abolish interaction with LptA and in cells expressing
LptCG56V the LptA level seems even higher than that
observed in cells expressing wild-type LptC. However,
LptCG56V impairs LPS transport, as demonstrated by the
decreased viability and the appearance of LPS decorated with
colanic acid in cells expressing the mutant protein only. These
data suggest that this mutation does not affect IM and OM
bridging by the Lpt complex, although the complex is not
functional. Since LptC has been shown to bind LPS in vitro
(38), it may be possible that the G56V mutation impairs such
binding. An alternative hypothesis can be that during LPS
transport LptC may undergo conformational changes, as sug-
gested by the recently reported crystal structure analysis (38),
that could be compromised by the G56V mutation.
The LptCG153R mutant protein displays a reduced affinity
to LptA since it is not able to copurify LptA. As for LptCG56,
FIG. 9. LptA level upon LptD and LptE depletion. (A and B) Growth curves of AM661 (araBp-lptD [A]) and AM689 (araBp-lptE [B]). Cells
growing exponentially in LD containing arabinose were harvested, washed, and subcultured in arabinose-supplemented (}) or arabinose-free ()
medium. Growth was monitored by measuring the OD600. (C) Steady-state levels of LptA. Samples for protein analysis taken from cells grown in
the presence () or absence () of arabinose at 210 min after the shift into nonpermissive condition were analyzed by Western blotting with
anti-LptA and anti-LptE antibodies. Equal amounts of cells (0.2 OD600 units) were loaded into each lane. AcrB was used as the loading control.
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G153 also falls in a stretch of conserved residues (38). The
inability of LptCG153R to copurify LptA suggests that the
binding determinants are located in the C-terminal region of
the protein. In cells expressing LptC or LptCG153R, the
LptA level is comparable, suggesting that the residual binding
activity of LptCG153R mutant protein, overexpressed from a
plasmid, is sufficient to prevent LptA degradation. Neverthe-
less, LptC-depleted FL905 cells expressing LptCG153R are
not viable (Fig. 2B) and accumulate colanic acid decorated
LPS (Fig. 5B), which indicates that transport is impaired.
LptC177-191 is highly unstable (Fig. 3A) and fails to interact
with LptA (Fig. 4), and thus the assembly of the Lpt complex
is compromised. Interestingly, the C-terminal deletion of
LptC177-191 removes the second disordered region of the pro-
tein (residues 185 to 191) (38). It is well established that un-
folded or only partly folded proteins in their native states fold
into an ordered structure on binding a partner molecule/pro-
tein (7, 8). A well-studied example is the binding of colicins to
disordered regions of their OM receptors as a key step in their
translocation into the target cell (12, 37). Therefore, the in-
trinsically disordered region in the C-terminal end of LptC
(residues 185 to 191) might be reorganized and folded upon
binding to LptA.
We show here that in the Lpt machinery, LptC interacts with
LptA. The recently solved crystal structure of LptC reveals a
striking structural similarity to LptA despite the fact that the
two proteins do not share sequence similarity (38). LptC is also
part of the LptBCFG complex (18). A possible candidate
for interaction in this complex is LptF since its periplasmic
loop displays a structural similarity to LptC (http://zhang
.bioinformatics.ku.edu/I-TASSER/). We provide evidence
here that LptC, when overexpressed, is also able to dimerize in
vivo (Fig. 6A). In addition to the in vivo data, size-exclusion
chromatography and ESI-MS experiments showed that a sol-
uble LptC version missing the N-terminal transmembrane do-
main (sH-LptC) forms dimers in vitro whose abundance in-
creases with increasing protein concentration and ionic
strength. In a very recent study it was reported that LptC exists
as a monomer in solution (38). It is possible that this discrep-
ancy is due to the different approaches and experimental con-
ditions used. However, we suggest that the dimeric form is not
the physiological preferred state in wild-type cells and that in
the Lpt complex a single LptC molecule is present; our data
suggest that LptC overexpression in vivo may shift the equilib-
rium between heterodimerization (interaction with LptA
and/or LptF in the LptBFG complex) and homodimerization.
It has been shown that the relative stoichiometry of the IM
PilM/N/O/P proteins is crucial in promoting pilus assembly in
P. aeruginosa. When overexpressed, PilO may form ho-
modimers. However, the heterodimer PilN/O is the physiolog-
ically preferred state, occurring when PilO is expressed from
the chromosome (1). The subunit ratio of the LptBCFG com-
plex (LptB/LptF/LptG/LptC) has been proposed to be 2:1:1:1
(predicted molecular mass of 157.2 kDa) (18). However, the
molecular mass of the LptBCFG complex determined by size-
exclusion chromatography was 
330 kDa (18), which would be
consistent with the ability of LptC to interact with itself, thus
resulting in dimerization of LptBCFG complex.
As discussed above, the LptC177-191 truncated protein is
intrinsically unstable, since it may expose unfolded regions and
become a protease substrate (40). Alternatively, LptC177-191
could not associate with the LptBFG complex and might thus
be degraded in the periplasm. In fact, it has been reported that
unbalanced expression of LptB in an LptFG wild-type back-
ground results in the loss of IM association and the degrada-
tion of soluble LptB molecules in the cytoplasm (18). LptC
could also be also stabilized by the interaction with LptA, the
level of which does indeed increase when the LptC depletion
strain FL905 is grown with arabinose. A similar codependence
has been observed for the IM divisome subcomplex FtsB/FtsL/
FtsQ, where it has been shown that FtsL and FtsB are code-
pendent for stabilization (10). However, our data (Fig. 7) sug-
gest that the stability of LptC does not depend on LptA. In
fact, upon LptE depletion LptA is undetectable since the OM
docking site is missing, but the LptC level is not affected.
In conclusion, we provide evidence here that depletion of
LptC, LptD, LptE, or mutations in LptC abolishing its function
break the Lpt machinery by impairing either its assembly
(LptC177-191) or functionality (LptCG153R and LptCG56V).
The lack of LptC (because the protein is depleted or mutated)
or LptDE removes the IM and OM LptA docking sites, and
the LptA level in the cell decreases. Based on these data, we
suggest that the steady-state level of LptA is controlled at the
protein stability level by the assembly of the Lpt complex since
the inability of the protein to properly interact with IM and
OM docking sites results in its degradation. Therefore, the
LptA level could be used as a marker of properly bridged IM
and OM components. Our genetic and biochemical data con-
firm that LptC plays a key role in docking LptA and other Lpt
factors at the IM, in addition to a direct role in LPS transport,
since the protein has also been shown to bind LPS (38). Over-
all, the data presented here strongly support the transenvelope
complex model for LPS transport.
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